ITOS NASDAQ
iTeos Therapeutics, Inc.
1W: -0.4%
1M: +0.1%
3M: +1.3%
1Y: -41.5%
3Y: -57.0%
5Y: -66.2%
$10.15
Last traded 2025-08-29 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-202M
Net Income
-87.2% YoY
$-109M
Free Cash Flow
+7.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-35.0%
ROA-29.4%
ROIC1062.6%
Valuation
P/E-3.9
P/B0.9
EV/EBITDA0.4
Leverage
Debt/Equity0.01
Current Ratio7.53
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z1.58
Beneish M0.00